We are live on
!
Find out more
ACA
Anchor Capital Advisors Portfolio holdings
AUM
$3.51B
1-Year Est. Return
16.99%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+16.99%
3 Year Est. Return
+54.72%
5 Year Est. Return
+78.01%
10 Year Est. Return
+273.33%
AUM
$2.75B
AUM Growth
+$25.9M
(+0.95%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-4.64%
Top 10 Holdings %
Top 10 Hldgs %
19.62%
Holding
288
New
13
Increased
39
Reduced
163
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$15.8M |
| 2 |
First Hawaiian
FHB
|
+$11.2M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$9.76M |
| 4 |
Booz Allen Hamilton
BAH
|
+$6.34M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$4.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Haemonetics
HAE
|
+$29.1M |
| 2 |
Omnicom Group
OMC
|
+$18.7M |
| 3 |
Broadridge
BR
|
+$15.2M |
| 4 |
Sysco
SYY
|
+$13.2M |
| 5 |
APA Corp
APA
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.4% |
| 2 | Healthcare | 15.22% |
| 3 | Technology | 14.09% |
| 4 | Industrials | 9.46% |
| 5 | Consumer Staples | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ubiquiti
UI
$31.6B
| $32.8M | 1.19% |
331,448
-4,038
| -1% | -$356K |
|
27
Pfizer
PFE
$143B
| $32.1M | 1.17% |
768,128
-26,507
| -3% | -$1.02M |
|
28
Occidental Petroleum
OXY
$55.7B
| $30.7M | 1.12% |
373,437
-17,322
| -4% | -$1.4M |
|
|
29
APA Corp
APA
$13B
| $30.7M | 1.11% |
643,176
-282,124
| -30% | -$12.7M |
|
30
Apple
AAPL
$4.97T
| $29.9M | 1.09% |
529,200
-46,680
| -8% | -$2.43M |
|
|
Y
31
DELISTED
Alleghany Corp
Y
| $29.4M | 1.07% |
45,014
-335
| -0.7% | -$210K |
|
32
PayPal
PYPL
$50.3B
| $28.9M | 1.05% |
328,712
-17,902
| -5% | -$1.58M |
|
33
Abbott
ABT
$188B
| $28.6M | 1.04% |
390,304
-17,271
| -4% | -$1.13M |
|
|
CDK
34
DELISTED
CDK Global, Inc.
CDK
| $28.5M | 1.04% |
456,291
+153,881
| +51% | +$9.76M |
|
35
Berkshire Hathaway Class B
BRK.B
$1.1T
| $28M | 1.02% |
130,740
-3,872
| -3% | -$794K |
|
36
Markel Group
MKL
$25.2B
| $28M | 1.02% |
23,549
-92
| -0.4% | -$108K |
|
37
Woodward
WWD
$23B
| $27.6M | 1.01% |
341,823
-1,110
| -0.3% | -$89.2K |
|
|
LSXMK
38
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $27.2M | 0.99% |
822,760
-8,303
| -1% | -$295K |
|
39
Amdocs
DOX
$6.03B
| $26.9M | 0.98% |
408,361
-320
| -0.1% | -$21.2K |
|
|
RDS.B
40
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $26.1M | 0.95% |
367,443
-8,659
| -2% | -$600K |
|
|
UN
41
DELISTED
Unilever NV New York Registry Shares
UN
| $25.8M | 0.94% |
464,537
-11,663
| -2% | -$660K |
|
42
Medtronic
MDT
$112B
| $25.4M | 0.92% |
258,397
-8,506
| -3% | -$786K |
|
43
Liberty Broadband Class C
LBRDK
$4.89B
| $24.6M | 0.9% |
292,310
+1,314
| +0.5% | +$105K |
|
44
EPAM Systems
EPAM
$5.58B
| $24M | 0.87% |
174,042
-1,540
| -0.9% | -$207K |
|
45
DuPont de Nemours
DD
$18.6B
| $23.8M | 0.86% |
145,858
-3,015
| -2% | -$519K |
|
46
Johnson & Johnson
JNJ
$640B
| $23.7M | 0.86% |
171,640
-5,680
| -3% | -$755K |
|
47
Ulta Beauty
ULTA
$21.8B
| $23.7M | 0.86% |
83,973
-55
| -0.1% | -$14K |
|
|
48
iShares Floating Rate Bond ETF
FLOT
$10.2B
| $23.6M | 0.86% |
461,742
+81,715
| +22% | +$4.17M |
|
49
Verizon
VZ
$197B
| $23.5M | 0.85% |
440,219
-16,395
| -4% | -$868K |
|
50
Hain Celestial
HAIN
$44.6M
| $23.3M | 0.85% |
860,299
-180,757
| -17% | -$5.16M |
|
Similar funds
TH
BCP
TYCC
TCM
DILIC
AAP
KCM
ACM
Anchor Capital Advisors's Q3 2018 Portfolio in Review
As of Q3 2018, Anchor Capital Advisors held 288 positions worth $2.75B, up 0.95% from $2.72B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Anchor Capital Advisors withdrew a net $128M in Q3 2018, closing 18 positions and reducing 163 holdings. Its most notable exit was Haemonetics, an estimated $29.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Anchor Capital Advisors opened a new position in Biogen worth $16.3M.
- Anchor Capital Advisors's largest Q3 2018 buy was Biogen: 46,021 shares worth $16.3M.
- Anchor Capital Advisors added most to CDK Global, Inc. in Q3 2018, an estimated $9.76M increase.
- Anchor Capital Advisors's biggest Q3 2018 reduction was Omnicom Group, cutting an estimated $18.7M.
- Anchor Capital Advisors fully exited Haemonetics in Q3 2018, selling an estimated $29.1M.
- Anchor Capital Advisors's ten largest holdings make up 20% of its $2.75B portfolio in Q3 2018.
- Anchor Capital Advisors opened 13 new positions and closed 18 in Q3 2018.
- Anchor Capital Advisors's portfolio value rose 0.95% quarter-over-quarter to $2.75B.
Based on Anchor Capital Advisors's 13F filing for Q3 2018, filed 31 Oct 2018.